<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320808">
  <stage>Registered</stage>
  <submitdate>24/11/2009</submitdate>
  <approvaldate>8/01/2010</approvaldate>
  <actrnumber>ACTRN12610000021077</actrnumber>
  <trial_identification>
    <studytitle>Clinical Evaluation of the AqueSys Implant for the Treatment of ocular hypertension and open angle glaucoma</studytitle>
    <scientifictitle>Clinical evaluation of the safety and effectiveness of the AqueSys implant in participants with poorly controlled intraocular pressure</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Ocular hypertension and open angle glaucoma</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The AqueSys Implant is implanted in the eye and is intended for the treatment of open angle glaucoma and ocular hypertension. The preloaded needle is inserted through the cornea and the needle is directed across the anterior chamber and implanted in the target quadrant of the eye. The implantation procedure will take approximately 30 minutes. The implant will remain permanently or until it is removed.</interventions>
    <comparator>N/A</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Safety and Effectiveness. Effectiveness will be evaluated by comparing baseline intraocular pressure values to postoperative values.</outcome>
      <timepoint>Post operative values taken at 1 day, 1 week, 2 week, 1 month, 3 month, 6 month, 9 month and 1 year.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Suitability of study procedure for use based on the successful application of the device.</outcome>
      <timepoint>Assessed during operative period.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Subjects with poorly controlled intraocular pressure.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1.	Angle Closure Glaucoma
2.	Congenital or other secondary glaucomas developed as a complication of other medical conditions</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>24/11/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Aquesys Inc</primarysponsorname>
    <primarysponsoraddress>26970 Aliso Viejo Parkway, Suite 200, Aliso Viejo, California 92656</primarysponsoraddress>
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Aquesys Inc</fundingname>
      <fundingaddress>26970 Aliso Viejo Parkway, Suite 200, Aliso Viejo, California 92656</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>PCRG</sponsorname>
      <sponsoraddress>PACIFIC CLINICAL RESEARCH GROUP
COURIER ADDRESS:
1 CASSINS AVENUE, SUITE G03
NORTH SYDNEY, NSW 2060
AUSTRALIA</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary objective of the study is to evaluate the safety and effectiveness of the AqueSys Implant for the treatment of ocular hypertension and open angle glaucoma.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Rupali N. Jobanputra</name>
      <address>Rupali N. Jobanputra Manager, Clinical Affairs AqueSys, Inc. 
26970 Aliso Viejo Parkway, Suite 200, Aliso Viejo, California 92656</address>
      <phone>+1 (949) 450-0250 x223</phone>
      <fax />
      <email>RJobanputra@AqueSys.com</email>
      <country>United States of America</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Rupali N. Jobanputra</name>
      <address>Rupali N. Jobanputra Manager, Clinical Affairs AqueSys, Inc. 
26970 Aliso Viejo Parkway, Suite 200, Aliso Viejo, California 92656.</address>
      <phone>+1 (949) 450-0250 x223</phone>
      <fax>+1 (949) 425-1012</fax>
      <email>RJobanputra@AqueSys.com</email>
      <country>United States of America</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Rupali N. Jobanputra</name>
      <address>Rupali N. Jobanputra Manager, Clinical Affairs AqueSys, Inc. 
26970 Aliso Viejo Parkway, Suite 200, Aliso Viejo, California 92656</address>
      <phone>+1 (949) 450-0250 x223</phone>
      <fax />
      <email>RJobanputra@AqueSys.com</email>
      <country>United States of America</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>